Pharmacy Podcast Network

Topic: Package Performance Qualification (PPQ) Testing for URAC 4.0 Compliance & PBM Contracting Participants and Roles:           Sheila Arquette, President & CEO, NASP, Host/Interviewer Katie Kraverath, Sr. Business Development Manager, Temptime Corporation Bill Barrows, Program Director, Partner’s Healthcare Specialty Pharmacy What you’ll learn: Why it’s important to perform seasonal package performance qualification (PPQ) testing. URAC and PBM requirements for PPQ Testing. Processes and methods of testing, including third-party testing vs in-house testing. An overview of changes to PPQ testing requirements per URAC’s new 4.0 version. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

If you didn’t document it, it didn’t happen.  In this episode of Beyond the Sig, Stephanie McGrath, PharmD, Executive Director of the Pennsylvania Pharmacists Care Network sits down with Josh Howland of PioneerRx and Kristen Hartzell of Hartzell’s Pharmacy to discuss how technology is supporting pharmacists in documenting their impact on patient care in an unprecedented way.  Documentation through the Pharmacist’s eCare Plan is a key component of the Flip the Pharmacy initiative, and a driver in community pharmacy practice innovation.  But at the end of the day, it’s just a story about a patient.   See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Every December, the American Diabetes Association updates the Standards of Medical Care in Diabetes. The guidelines cover sixteen sections from diabetes advocacy to technology updates. Start 2021 off right - learn what changed and what matters most for individuals with diabetes. This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! Reference: American Diabetes Association. Standards of Medical Care in Diabetes - 2021. Diabetes Cares. January 01, 2021; volume 44, issue supplement 1. https://care.diabetesjournals.org/content/44/Supplement_1  Disclosure: Dr. Jake Galdo is a speaker for Novo Nordisk in 2021. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Becky Winslow, PharmD & Pharmacy Student Kaitlyn Marshall re-launch the PGX for Pharmacists.  23andMe announced in August of 2020 that it has received a 510(k) clearance from the FDA that allows its direct-to-consumer personal pharmacogenetics report to guide use of two treatments without the need for confirmatory testing. This action updates a De Novo approval granted to the consumer genomics company in late 2018. That decision allowed 23andMe to market a test for one of 33 variants across multiple genes that could impact metabolization of certain medication, but came with a handful of "special controls." Among these were labeling requirements that warned consumers not to use the product for any medication decisions without additional independent testing. Guests:  Becky Winslow, BS, PharmD - Medical Affairs  Dr. Becky Winslow, earned both her Bachelors of Science in Biology and her doctorate in clinical pharmacy from Campbell University. She earned her Test2Learn(TM) Community-Based Pharmacogenomics Certificate, as well as, her  "Train the Trainer"  certification through NACDS and The University of Pittsburgh School of Pharmacy.  Dr. Winslow brings over 20 years experience building clinical pharmacy programs, as well as, directing pharmacy business operations in the community setting to inGENEiosu RX. She has patient facing clinical experience as a pharmacist in retail, hospital, public health, and long term care pharmacies. Dr. Winslow founded and has owned her general pharmacy consulting business for over 20 years. In the last 6 years, she has specialized in pharmacogenomics consulting.  Dr. Winslow's professional associations include being a member of the Clinical Pharmacogenetics Implementation Consortium and The Get the Medications Right Institute. Now recognized as a community pharmacogenomics subject matter expert, Dr. Winslow is sought after to create and present original pharmacogenomics content and to consult for pharmacogenomics industry vendors and the clients they serve. Kaitlyn Marshall - PharmD Candidate 2021 See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

On this episode of Beyond the Sig, Brooke Kulusich, third-year student pharmacist at the University of Pittsburgh School of Pharmacy, talks with Cameron Carpenter, fourth-year student pharmacist at Wilkes Nesbitt School of Pharmacy. In this student-to-student conversation, they discuss ways to engage student pharmacists in practice transformation efforts and Cameron shares his experience from completing an elective community APPE rotation at leading PPCN pharmacies across the state. Beyond the Sig https://www.papharmacists.com/page/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Look at the big picture with a MOBE Pharmacist. From your past health history to any new or recent treatments, a MOBE Pharmacist is here to help you put it all together. They help you build the best medication plan for your health goals by looking at all your prescriptions—across providers, pharmacies, and clinics—and listening to your concerns, as well as what has or hasn’t worked in the past. You’ll also learn more about how any over-the-counter drugs, dietary supplements, and/or herbal remedies fit into your treatment plan. Your pharmacist will partner with your MOBE Guide to optimize any lifestyle changes you might make to best support your medication situation. When access isn’t enough: Solving a paradox to serve healthcare’s hidden population. By: Chris Cronin, Chief Executive Officer https://www.mobeforlife.com/resources/when-access-isnt-enough-solving-a-paradox-to-serve-healthcares-hidden-population Promoting patient engagement to prevent readmissions By: Leslie Helou, Vice President of Guided Medication Programming https://www.mobeforlife.com/resources/promoting-patient-engagement-to-prevent-readmissions Our guests: Leslie Helou, PharmD, BCPS Vice President of Medication Strategies Leslie designs medication initiatives for MOBE participants that are hyper-personalized. These action plans address the complexity of each medication while highlighting the important role they can play when achieving health goals. She inspires her team to help others think critically about, understand, and get the best results possible from their medications while also making other healthy choices. Prior to joining MOBE, Leslie built a career at Upsher-Smith Laboratories, leading efforts to incorporate patient, provider, researcher, and advocacy group insights early in the pharmaceutical research and development process. Leslie received a doctorate in pharmacy from the University of Minnesota College of Pharmacy before completing a multi-year post-graduate residency in pharmaceutical care and leadership and becoming board certified in pharmacotherapy. She is passionate about mentoring and keeps a relationship with the University to provide unique, business-focused experiences to pharmacy students and graduates.  Chris Cronin Chief Executive Officer Chris leads corporate direction and strategy at MOBE and is motivated daily by guiding the team to do good together. He previously served as the company’s Chief Operating Officer. Prior to joining MOBE, Chris held various leadership positions at Medtronic in the Cardiac and Restorative Therapies Group, including European Business Director and leading the commercialization of the world’s first MR-Conditional Pacemaker. Chris has a BS in Accounting from St. John’s University and an MBA from The University of Notre Dame. He lives an active, healthy lifestyle and has completed 15 marathons and three Ironman triathlons, but still loves a big bowl of ice cream. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

In 2013, Congress passed the Drug Supply Chain Security Act, often called the “track and trace” law, which is designed protect consumers against counterfeit drugs. In November 2020, new requirements for pharmacists took effect. To learn more about what pharmacists need to know, we spoke with Ilisa Bernstein, senior vice president for government affairs and pharmacy practice at APhA; and Leigh Verbois, director of the Office of Drug Security, Integrity and Response for the FDA’s Center for Drug Evaluation and Research.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

We're not talking about drugs made by Louis Vuitton or Dior, no. We're talking about drugs designed to circumvent existing laws by pushing the boundaries of chemistry. Brought to you by the hilarious Ivan Stewart, this episode will entertain as we explore the world of designer drugs. This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics! Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com. PLEASE READ: Shane and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health, A special thanks to Kelly Kerr for creating the music used in the intro and outro. All Rights Reserved Sponsored by: UltiGuard Safe Pack is the only pen needle product that comes with an all-in-one sharps container. Learn more about why UltiGuard Safe Pack is the best choice for your patients and your pharmacy. Learn more UltiGuard Safe Pack https://www.ulticare.com/ultiguard-safe-pack/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Myopathy is a common reason for discontinuation of statin medications. The recent SAMSON study examined the nocebo effect and how this may bias patients towards treatment failure. How can clinicians overcome the nocebo effect? This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! Reference: Wood F, Howard J, Finegold J, et al. N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects. N Engl J Med 2020; 383:2182-2184. DOI: 10.1056/NEJMc2031173 See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

The efficacy of antiretroviral therapy has led to persons with HIV living a near-normal lifespan. But medications only work when used appropriately. The International Antiviral Society-USA Panel published updated recommendations for the treatment and prevention of HIV infections. Treatment of HIV may be distilled into a simple idea - two "nucs" and something else. Learn how to optimize care for your patients. This episode is accredited for CPE. Subscribe at CEimpact (https://www.ceimpact.com/pharmacist) and claim your CE today! Reference: Saag MS, Gandhi RT, Hoy JF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society-USA Panel. JAMA. 2020;324(16):1651-1669. Available at: https://www.iasusa.org/2020/11/12/antiretroviral-drugs-treatment-prevention-hiv-infection-adults-2020-recommendations-of-the-international-antiviral-society-usa-panel/  The CE for this episode is supported by an educational grant from Xellia Pharmaceuticals, a specialty pharmaceutical company focused on providing important anti-infective treatments against serious and often life-threatening infections.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices